Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wang YY et al. – After the BBB–targeting vector–therapeutic conjugates have crossed the BBB, there may still be a need to target them to a specific population of cells in the brain. This review will focus on two major aspects of RMT brain drug delivery: new advances of existing RMT systems and development of new BBB transport vectors and specific RMT targets.

Today in Clinical Pharmacology...keeping you current

Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
Journal of Allergy and Clinical Immunology, 11/25/09

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09

High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations
Journal of Allergy and Clinical Immunology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address